Gaudium IVF and Women Health Limited
Healthcare›Healthcare›Healthcare Services›Healthcare Service Provider
Key metrics
Price as of 2026-04-27
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Only consolidated filings are available for this company — standalone cannot be selected.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Dec 2025 | Mar 2026 |
|---|---|---|
| Sales | 25 Cr | 30 Cr |
| Operating expenses (approx.) | 18 Cr | 18 Cr |
| EBITDA | 7 Cr | 12 Cr |
| OPM % | 27.2% | 40.7% |
| Other income | 0.10 Cr | 0.18 Cr |
| Interest | 1 Cr | 1 Cr |
| Depreciation | 0.49 Cr | 0.64 Cr |
| Profit before tax | 5 Cr | 10 Cr |
| Tax % | 26.9% | 19.8% |
| Net profit | 4 Cr | 8 Cr |
| EPS (₹) | ₹0.59 | ₹1.34 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2026 | TTM |
|---|---|---|
| Sales | 104 Cr | Sign in for TTM |
| Operating expenses (approx.) | 66 Cr | Sign in for TTM |
| EBITDA | 38 Cr | Sign in for TTM |
| OPM % | 36.6% | Sign in for TTM |
| Other income | 0.53 Cr | Sign in for TTM |
| Interest | 3 Cr | Sign in for TTM |
| Depreciation | 3 Cr | Sign in for TTM |
| Profit before tax | 32 Cr | Sign in for TTM |
| Tax % | 23.9% | Sign in for TTM |
| Net profit | 24 Cr | Sign in for TTM |
| EPS (₹) | ₹3.92 | Sign in for TTM |
| Dividend payout % | 0.0% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2026 |
|---|---|
| Equity capital | 36 Cr |
| Reserves | 116 Cr |
| Borrowings | 23 Cr |
| Other liabilities | 18 Cr |
| Total liabilities | 193 Cr |
| Fixed assets (net) | 7 Cr |
| CWIP | 0.0000 Cr |
| Investments | 5 Cr |
| Other assets | 73 Cr |
| Total assets | 193 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2026 |
|---|---|
| Cash from operating activity | 7 Cr |
| Cash from investing | -88 Cr |
| Cash from financing | 82 Cr |
| Net cash flow | 2 Cr |
| Free cash flow (OCF − Capex) | 5 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2026 |
|---|---|
| ROCE % | 20.3% |
| ROE % | 16.1% |
| Debtor days | — |
| Inventory days | 12 |
| Days payable | — |
| Cash conversion cycle | 12 |
| Debt / equity | 0.15 |
| Current ratio | 1.90 |
| Net debt / EBITDA | 0.37 |
Compare with peers
Loading peers…